Rayner Surgical Group Limited
Rayner Surgical Group Limited, commonly known as Rayner, is a leading British ophthalmic company headquartered in GB. Founded in 1910, Rayner has established itself as a pioneer in the field of eye care, particularly in the development of innovative intraocular lenses and surgical solutions. With a strong presence in Europe, Asia, and the Americas, the company has achieved significant milestones, including the introduction of the first-ever foldable intraocular lens. Rayner's core offerings include a range of advanced intraocular lenses, surgical instruments, and diagnostic equipment, all designed to enhance patient outcomes and streamline surgical procedures. Renowned for their commitment to quality and innovation, Rayner has positioned itself as a trusted partner in the ophthalmic industry, consistently delivering products that meet the evolving needs of eye care professionals.
DitchCarbon Score
How does Rayner Surgical Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Rayner Surgical Group Limited's score of 21 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Rayner Surgical Group Limited's reported carbon emissions
In 2023, Rayner Surgical Group Limited reported total carbon emissions of approximately 25,926,000 kg CO2e. This figure includes 1,250,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 1,406,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, about 23,926,000 kg CO2e, fall under Scope 3, which encompasses all other indirect emissions that occur in the value chain. Comparatively, in 2021, the company recorded total emissions of approximately 24,000,000 kg CO2e, with Scope 1 emissions at 763,000 kg CO2e, Scope 2 emissions at 1,077,000 kg CO2e, and Scope 3 emissions at 23,269,000 kg CO2e. This indicates a slight increase in total emissions over the two years. Currently, Rayner Surgical Group Limited has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. Their climate commitments and strategies remain unspecified, which places them in a broader industry context where many companies are actively pursuing carbon reduction goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2023 | |
|---|---|---|
| Scope 1 | 763,000 | 0,000,000 |
| Scope 2 | 1,077,000 | 0,000,000 |
| Scope 3 | 23,269,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Rayner Surgical Group Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
